Library / regulatory-reference
Uruguay: Ministry of Public Health (MSP)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Ministry of Public Health, known by its Spanish initials MSP, is Uruguay's national regulatory authority for medicines.
Uruguay's small market combines imports with a domestic pharmaceutical industry oriented toward generics and regional export, and the ministry's registration and inspection decisions cover both.
How products enter the market
Medicines require registration after evaluation of quality, safety and efficacy documentation, and establishments are licensed and inspected by the ministry's health-control services.
Post-market work includes safety monitoring, quality surveillance and recalls, operating within a health system that mixes public provision with private mutual-insurance funds.
Regional and international role
Uruguay participates in regional regulatory cooperation in South America, where harmonization and reliance among neighboring authorities are active themes.
Its compact but institutionally stable system is often cited as an example of a small-country regulator with consistent practice.
Using this profile
The ministry publishes regulations and announcements in Spanish through its official portal on the national government platform, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: Uruguay illustrates the small-state ministry regulator: a compact authority covering imports and a regional-facing domestic industry.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.